Added value of H-FABP as a plasma biomarker for the early evaluation of suspected acute coronary syndrome
Authors:
- 1 April 2014
- journal article
- review article
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 9 (2) , 205-220
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Increased H-FABP concentrations in nonalcoholic fatty liver diseaseHerz, 2013
- Laboratory diagnostics of myocardial infarction – troponins and beyondClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial InfarctionJAMA, 2011
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- CARDIODETECT RAPID TEST FOR THE DIAGNOSIS OF EARLY ACUTE MYOCARDIAL INFARCTIONJournal of Immunoassay and Immunochemistry, 2011
- Evaluation of Four Rapid Immunochromatographic Tests for the Detection of Cardiac Troponin IClinical and Vaccine Immunology, 2011
- Heart-type Fatty Acid Binding Protein as an Adjunct to Cardiac Troponin-I for the Diagnosis of Myocardial InfarctionJournal of Korean Medical Science, 2011
- Heart-Type Fatty Acid Binding Protein Is an Independent Predictor of Death and Ventricular Dysfunction After Coronary Artery Bypass Graft SurgeryAnesthesia & Analgesia, 2010
- Estimation of Myocardial Infarct Size from Plasma Myoglobin or Fatty Acid-Binding Protein. Influence of Renal FunctionClinical Chemistry and Laboratory Medicine (CCLM), 1997
- On the Mechanism of Long Chain Fatty Acid Transport in Cardiomyocytes as Facilitated by Cytoplasmic Fatty Acid-binding ProteinJournal of Theoretical Biology, 1993